Position in ERAS
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$28,903,772
+$22,298,226 QoQ
Shares Held
1,786,389
+0.6% QoQ
Ownership
0.574%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 79.38209426950121.ToString("F0")%
Shared 9.504088975021679.ToString("F0")%
None 11.11381675547711.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. ERAS ranks #43 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in ERAS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,903,772 | 1,786,389 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $6,605,546 | 1,775,685 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,990,817 | 1,371,935 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,150,646 | 1,693,423 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,518,234 | 1,838,128 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,301,082 | 2,111,986 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,298,655 | 1,208,299 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,180,136 | 500,058 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $659,737 | 320,261 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $801,280 | 376,188 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $373,442 | 189,565 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $119,706 | 43,372 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $241,931 | 80,376 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $265,444 | 61,588 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||